A cGMP inhibitor, LY83583, inhibited the stomatal replies to bicarbonate, darkness, and ABA treatments by 55
A cGMP inhibitor, LY83583, inhibited the stomatal replies to bicarbonate, darkness, and ABA treatments by 55.6, 41.2, and 76.1%, respectively, compared with the control conditions… Read More »A cGMP inhibitor, LY83583, inhibited the stomatal replies to bicarbonate, darkness, and ABA treatments by 55